Stock MNKKQ MALLINCKRODT
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Mallinckrodt OTC Markets

Equities

MNKKQ

IE00BBGT3753

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Mallinckrodt plc Presents Data on Terlipressin for Injection in Patients with Hepatorenal Syndrome at the 2024 European Association for the Study of the Liver Congress
CI
Mallinckrodt plc Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome at the 2024 Digestive Disease Week®
CI
Mallinckrodt plc Reports Earnings Results for the First Quarter Ended March 29, 2024
CI
Mallinckrodt plc Reaffirms Financial Guidance for the Full Year of 2024
CI
Mallinckrodt plc Reports Earnings Results for the Full Year Ended December 29, 2023
CI
Mallinckrodt plc Reports Earnings Results for the Fourth Quarter Ended December 29, 2023
CI
Mallinckrodt plc Provides Earnings Guidance for the Year 2024
CI
Mallinckrodt Appoints Paul O'neill as Executive Vice President, Quality & Operations, Specialty Brands
CI
Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ for Injection in Adults with Hepatorenal Syndrome
AQ
Mallinckrodt Announces FDA Clearance of the INOmax EVOLVE DS Delivery System and Approval of the INOmax Mini-Cylinder
AQ
Mallinckrodt plc Announces FDA Clearance of the INOmax® EVOLVE? DS Delivery System and Approval of the INOmax® Mini-Cylinder
CI
Mallinckrodt plc Announces Resignation of Sigurdur Olafsson as Chief Executive Officer
CI
Mallinckrodt plc Announces Board Changes
CI
Drugmaker Mallinckrodt emerges from bankruptcy
RE
Drugmaker Mallinckrodt emerges from bankruptcy
RE
Mallinckrodt plc Emerged from Bankruptcy
CI
Mallinckrodt to Present Breadth of Data on TERLIVAZ for Injection in Adult Patients with Hepatorenal Syndrome at the American Association for the Study of Liver Diseases 2023 Liver Meeting
AQ
Mallinckrodt plc to Present Breadth of Data on Terlivaz (Terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome At the American Association for the Study of Liver Diseases 2023 Liver Meeting
CI
Mallinckrodt: Q3 Earnings Snapshot
AQ
Mallinckrodt plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MNK Stock
  4. MNKKQ Stock
  5. News Mallinckrodt